nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—RRM2—urinary bladder cancer	0.519	1	CbGaD
Gallium nitrate—RRM2—Gemcitabine—urinary bladder cancer	0.29	1	CbGbCtD
Gallium nitrate—BGLAP—urine—urinary bladder cancer	0.00779	0.136	CbGeAlD
Gallium nitrate—TF—urine—urinary bladder cancer	0.00594	0.104	CbGeAlD
Gallium nitrate—ATP6V1B2—prostate gland—urinary bladder cancer	0.00327	0.0571	CbGeAlD
Gallium nitrate—ATP6V1B2—seminal vesicle—urinary bladder cancer	0.00276	0.0483	CbGeAlD
Gallium nitrate—Lung infiltration—Mitomycin—urinary bladder cancer	0.0026	0.0515	CcSEcCtD
Gallium nitrate—IL1B—prostate gland—urinary bladder cancer	0.00239	0.0418	CbGeAlD
Gallium nitrate—ATP6V1B2—renal system—urinary bladder cancer	0.00223	0.0389	CbGeAlD
Gallium nitrate—ATP6V1B2—urethra—urinary bladder cancer	0.00219	0.0382	CbGeAlD
Gallium nitrate—TF—prostate gland—urinary bladder cancer	0.00213	0.0373	CbGeAlD
Gallium nitrate—RRM2—prostate gland—urinary bladder cancer	0.00211	0.0368	CbGeAlD
Gallium nitrate—BGLAP—renal system—urinary bladder cancer	0.00191	0.0333	CbGeAlD
Gallium nitrate—ATP6V1B2—female reproductive system—urinary bladder cancer	0.00178	0.0312	CbGeAlD
Gallium nitrate—IL1B—epithelium—urinary bladder cancer	0.00176	0.0307	CbGeAlD
Gallium nitrate—IL1B—smooth muscle tissue—urinary bladder cancer	0.00169	0.0296	CbGeAlD
Gallium nitrate—IL1B—renal system—urinary bladder cancer	0.00163	0.0285	CbGeAlD
Gallium nitrate—ATP6V1B2—vagina—urinary bladder cancer	0.00161	0.0282	CbGeAlD
Gallium nitrate—TF—epithelium—urinary bladder cancer	0.00157	0.0274	CbGeAlD
Gallium nitrate—BGLAP—female reproductive system—urinary bladder cancer	0.00153	0.0267	CbGeAlD
Gallium nitrate—TF—renal system—urinary bladder cancer	0.00145	0.0254	CbGeAlD
Gallium nitrate—RRM2—renal system—urinary bladder cancer	0.00144	0.0251	CbGeAlD
Gallium nitrate—IL1B—female reproductive system—urinary bladder cancer	0.00131	0.0228	CbGeAlD
Gallium nitrate—IL1B—vagina—urinary bladder cancer	0.00118	0.0206	CbGeAlD
Gallium nitrate—TF—female reproductive system—urinary bladder cancer	0.00116	0.0203	CbGeAlD
Gallium nitrate—RRM2—female reproductive system—urinary bladder cancer	0.00115	0.0201	CbGeAlD
Gallium nitrate—RRM2—Azacitidine—Gemcitabine—urinary bladder cancer	0.00111	1	CbGdCrCtD
Gallium nitrate—Lung infiltration—Gemcitabine—urinary bladder cancer	0.0011	0.0218	CcSEcCtD
Gallium nitrate—TF—vagina—urinary bladder cancer	0.00105	0.0184	CbGeAlD
Gallium nitrate—ATP6V1B2—lymph node—urinary bladder cancer	0.00104	0.0182	CbGeAlD
Gallium nitrate—RRM2—vagina—urinary bladder cancer	0.00104	0.0182	CbGeAlD
Gallium nitrate—Encephalopathy—Thiotepa—urinary bladder cancer	0.000957	0.0189	CcSEcCtD
Gallium nitrate—Oedema peripheral—Valrubicin—urinary bladder cancer	0.000877	0.0173	CcSEcCtD
Gallium nitrate—Blindness—Cisplatin—urinary bladder cancer	0.00087	0.0172	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Cisplatin—urinary bladder cancer	0.000828	0.0164	CcSEcCtD
Gallium nitrate—Encephalopathy—Fluorouracil—urinary bladder cancer	0.000791	0.0156	CcSEcCtD
Gallium nitrate—Optic neuritis—Cisplatin—urinary bladder cancer	0.000783	0.0155	CcSEcCtD
Gallium nitrate—IL1B—lymph node—urinary bladder cancer	0.000763	0.0133	CbGeAlD
Gallium nitrate—Neoplasm malignant—Thiotepa—urinary bladder cancer	0.000719	0.0142	CcSEcCtD
Gallium nitrate—Optic neuritis—Etoposide—urinary bladder cancer	0.000717	0.0142	CcSEcCtD
Gallium nitrate—Anaemia—Valrubicin—urinary bladder cancer	0.000716	0.0142	CcSEcCtD
Gallium nitrate—TF—lymph node—urinary bladder cancer	0.000681	0.0119	CbGeAlD
Gallium nitrate—Pleural effusion—Gemcitabine—urinary bladder cancer	0.000675	0.0133	CcSEcCtD
Gallium nitrate—RRM2—lymph node—urinary bladder cancer	0.000672	0.0118	CbGeAlD
Gallium nitrate—Hearing impaired—Thiotepa—urinary bladder cancer	0.000645	0.0128	CcSEcCtD
Gallium nitrate—Rales—Methotrexate—urinary bladder cancer	0.000644	0.0127	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Gemcitabine—urinary bladder cancer	0.000605	0.012	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Gemcitabine—urinary bladder cancer	0.000564	0.0112	CcSEcCtD
Gallium nitrate—Lung infiltration—Methotrexate—urinary bladder cancer	0.000563	0.0111	CcSEcCtD
Gallium nitrate—Hearing impaired—Gemcitabine—urinary bladder cancer	0.000543	0.0107	CcSEcCtD
Gallium nitrate—Erythema—Mitomycin—urinary bladder cancer	0.000534	0.0106	CcSEcCtD
Gallium nitrate—Feeling abnormal—Valrubicin—urinary bladder cancer	0.000521	0.0103	CcSEcCtD
Gallium nitrate—Hearing impaired—Cisplatin—urinary bladder cancer	0.000506	0.01	CcSEcCtD
Gallium nitrate—Body temperature increased—Valrubicin—urinary bladder cancer	0.0005	0.00988	CcSEcCtD
Gallium nitrate—Anaemia—Mitomycin—urinary bladder cancer	0.000493	0.00976	CcSEcCtD
Gallium nitrate—Leukopenia—Mitomycin—urinary bladder cancer	0.000478	0.00945	CcSEcCtD
Gallium nitrate—Coma—Fluorouracil—urinary bladder cancer	0.000464	0.00918	CcSEcCtD
Gallium nitrate—Body temperature increased—Carboplatin—urinary bladder cancer	0.000463	0.00915	CcSEcCtD
Gallium nitrate—Pruritus—Valrubicin—urinary bladder cancer	0.000447	0.00885	CcSEcCtD
Gallium nitrate—Blindness—Epirubicin—urinary bladder cancer	0.000447	0.00883	CcSEcCtD
Gallium nitrate—Hypothermia—Epirubicin—urinary bladder cancer	0.000441	0.00872	CcSEcCtD
Gallium nitrate—Body temperature decreased—Epirubicin—urinary bladder cancer	0.000441	0.00872	CcSEcCtD
Gallium nitrate—Confusional state—Mitomycin—urinary bladder cancer	0.000439	0.00869	CcSEcCtD
Gallium nitrate—Diarrhoea—Valrubicin—urinary bladder cancer	0.000433	0.00856	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Epirubicin—urinary bladder cancer	0.000425	0.00841	CcSEcCtD
Gallium nitrate—Blindness—Doxorubicin—urinary bladder cancer	0.000413	0.00817	CcSEcCtD
Gallium nitrate—Encephalopathy—Methotrexate—urinary bladder cancer	0.000412	0.00814	CcSEcCtD
Gallium nitrate—Hypothermia—Doxorubicin—urinary bladder cancer	0.000408	0.00807	CcSEcCtD
Gallium nitrate—Body temperature decreased—Doxorubicin—urinary bladder cancer	0.000408	0.00807	CcSEcCtD
Gallium nitrate—Vomiting—Valrubicin—urinary bladder cancer	0.000402	0.00795	CcSEcCtD
Gallium nitrate—Optic neuritis—Epirubicin—urinary bladder cancer	0.000402	0.00795	CcSEcCtD
Gallium nitrate—Rash—Valrubicin—urinary bladder cancer	0.000399	0.00788	CcSEcCtD
Gallium nitrate—Dermatitis—Valrubicin—urinary bladder cancer	0.000398	0.00788	CcSEcCtD
Gallium nitrate—Hypophosphataemia—Doxorubicin—urinary bladder cancer	0.000394	0.00778	CcSEcCtD
Gallium nitrate—Dyspnoea—Mitomycin—urinary bladder cancer	0.000388	0.00768	CcSEcCtD
Gallium nitrate—Renal failure acute—Cisplatin—urinary bladder cancer	0.000379	0.00749	CcSEcCtD
Gallium nitrate—Lethargy—Fluorouracil—urinary bladder cancer	0.000376	0.00744	CcSEcCtD
Gallium nitrate—Nausea—Valrubicin—urinary bladder cancer	0.000376	0.00743	CcSEcCtD
Gallium nitrate—Optic neuritis—Doxorubicin—urinary bladder cancer	0.000372	0.00735	CcSEcCtD
Gallium nitrate—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000359	0.0071	CcSEcCtD
Gallium nitrate—Pleural effusion—Methotrexate—urinary bladder cancer	0.000345	0.00682	CcSEcCtD
Gallium nitrate—Body temperature increased—Mitomycin—urinary bladder cancer	0.000344	0.00681	CcSEcCtD
Gallium nitrate—Pleural effusion—Epirubicin—urinary bladder cancer	0.000323	0.00638	CcSEcCtD
Gallium nitrate—Hallucination—Thiotepa—urinary bladder cancer	0.000307	0.00607	CcSEcCtD
Gallium nitrate—Pleural effusion—Doxorubicin—urinary bladder cancer	0.000299	0.00591	CcSEcCtD
Gallium nitrate—Diarrhoea—Mitomycin—urinary bladder cancer	0.000298	0.00589	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Epirubicin—urinary bladder cancer	0.00029	0.00573	CcSEcCtD
Gallium nitrate—Tinnitus—Thiotepa—urinary bladder cancer	0.000288	0.00569	CcSEcCtD
Gallium nitrate—Vomiting—Mitomycin—urinary bladder cancer	0.000277	0.00548	CcSEcCtD
Gallium nitrate—Rash—Mitomycin—urinary bladder cancer	0.000275	0.00543	CcSEcCtD
Gallium nitrate—Dermatitis—Mitomycin—urinary bladder cancer	0.000274	0.00543	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Epirubicin—urinary bladder cancer	0.00027	0.00534	CcSEcCtD
Gallium nitrate—Erythema—Thiotepa—urinary bladder cancer	0.000268	0.00531	CcSEcCtD
Gallium nitrate—Neoplasm malignant—Doxorubicin—urinary bladder cancer	0.000268	0.0053	CcSEcCtD
Gallium nitrate—Nausea—Mitomycin—urinary bladder cancer	0.000259	0.00512	CcSEcCtD
Gallium nitrate—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.000256	0.00505	CcSEcCtD
Gallium nitrate—Hypocalcaemia—Doxorubicin—urinary bladder cancer	0.00025	0.00494	CcSEcCtD
Gallium nitrate—Anaemia—Thiotepa—urinary bladder cancer	0.000248	0.00491	CcSEcCtD
Gallium nitrate—Coma—Methotrexate—urinary bladder cancer	0.000241	0.00477	CcSEcCtD
Gallium nitrate—Leukopenia—Thiotepa—urinary bladder cancer	0.00024	0.00475	CcSEcCtD
Gallium nitrate—Coma—Epirubicin—urinary bladder cancer	0.000226	0.00447	CcSEcCtD
Gallium nitrate—Erythema—Gemcitabine—urinary bladder cancer	0.000226	0.00447	CcSEcCtD
Gallium nitrate—Tinnitus—Cisplatin—urinary bladder cancer	0.000225	0.00446	CcSEcCtD
Gallium nitrate—Erythema—Fluorouracil—urinary bladder cancer	0.000222	0.00439	CcSEcCtD
Gallium nitrate—Confusional state—Thiotepa—urinary bladder cancer	0.000221	0.00437	CcSEcCtD
Gallium nitrate—Tachycardia—Thiotepa—urinary bladder cancer	0.000214	0.00423	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.000213	0.00258	CbGpPWpGaD
Gallium nitrate—IL1B—IFN-gamma pathway—EP300—urinary bladder cancer	0.000212	0.00257	CbGpPWpGaD
Gallium nitrate—Erythema—Cisplatin—urinary bladder cancer	0.00021	0.00416	CcSEcCtD
Gallium nitrate—Coma—Doxorubicin—urinary bladder cancer	0.000209	0.00413	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000209	0.00253	CbGpPWpGaD
Gallium nitrate—Anaemia—Gemcitabine—urinary bladder cancer	0.000209	0.00413	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—IFNA2—urinary bladder cancer	0.000208	0.00252	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Methotrexate—urinary bladder cancer	0.000208	0.00411	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—CREBBP—urinary bladder cancer	0.000207	0.00251	CbGpPWpGaD
Gallium nitrate—RRM2—E2F transcription factor network—RB1—urinary bladder cancer	0.000207	0.0025	CbGpPWpGaD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	0.000207	0.0025	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—SLC19A1—urinary bladder cancer	0.000206	0.0025	CbGpPWpGaD
Gallium nitrate—Anaemia—Fluorouracil—urinary bladder cancer	0.000205	0.00406	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000202	0.00245	CbGpPWpGaD
Gallium nitrate—TF—EPHB forward signaling—HRAS—urinary bladder cancer	0.000202	0.00245	CbGpPWpGaD
Gallium nitrate—Leukopenia—Gemcitabine—urinary bladder cancer	0.000202	0.004	CcSEcCtD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000201	0.00243	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PRSS3—urinary bladder cancer	0.000201	0.00243	CbGpPWpGaD
Gallium nitrate—Leukopenia—Fluorouracil—urinary bladder cancer	0.000199	0.00393	CcSEcCtD
Gallium nitrate—Paraesthesia—Thiotepa—urinary bladder cancer	0.000197	0.00389	CcSEcCtD
Gallium nitrate—Lethargy—Methotrexate—urinary bladder cancer	0.000196	0.00387	CcSEcCtD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000195	0.00237	CbGpPWpGaD
Gallium nitrate—Anaemia—Cisplatin—urinary bladder cancer	0.000195	0.00385	CcSEcCtD
Gallium nitrate—Renal failure acute—Epirubicin—urinary bladder cancer	0.000194	0.00384	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000194	0.00235	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—TNF—urinary bladder cancer	0.000194	0.00235	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HDAC4—urinary bladder cancer	0.000191	0.00232	CbGpPWpGaD
Gallium nitrate—RRM2—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000191	0.00231	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CCNE1—urinary bladder cancer	0.00019	0.0023	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	0.000189	0.00229	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000188	0.00228	CbGpPWpGaD
Gallium nitrate—Leukopenia—Cisplatin—urinary bladder cancer	0.000188	0.00373	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000188	0.00227	CbGpPWpGaD
Gallium nitrate—Constipation—Thiotepa—urinary bladder cancer	0.000187	0.0037	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—TYMS—urinary bladder cancer	0.000186	0.00226	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—PLAU—urinary bladder cancer	0.000185	0.00224	CbGpPWpGaD
Gallium nitrate—Lethargy—Epirubicin—urinary bladder cancer	0.000183	0.00362	CcSEcCtD
Gallium nitrate—Confusional state—Fluorouracil—urinary bladder cancer	0.000183	0.00361	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—CDKN2A—urinary bladder cancer	0.000182	0.0022	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—KRAS—urinary bladder cancer	0.000182	0.0022	CbGpPWpGaD
Gallium nitrate—IL1B—IL12-mediated signaling events—IL2—urinary bladder cancer	0.000181	0.00219	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000181	0.00357	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—RHOA—urinary bladder cancer	0.00018	0.00219	CbGpPWpGaD
Gallium nitrate—Renal failure acute—Doxorubicin—urinary bladder cancer	0.00018	0.00356	CcSEcCtD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	0.00018	0.00218	CbGpPWpGaD
Gallium nitrate—Anaemia—Etoposide—urinary bladder cancer	0.000178	0.00352	CcSEcCtD
Gallium nitrate—Tachycardia—Fluorouracil—urinary bladder cancer	0.000177	0.0035	CcSEcCtD
Gallium nitrate—Body temperature increased—Thiotepa—urinary bladder cancer	0.000173	0.00342	CcSEcCtD
Gallium nitrate—Leukopenia—Etoposide—urinary bladder cancer	0.000173	0.00341	CcSEcCtD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000171	0.00207	CbGpPWpGaD
Gallium nitrate—Lethargy—Doxorubicin—urinary bladder cancer	0.000169	0.00335	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—ESPL1—urinary bladder cancer	0.000169	0.00205	CbGpPWpGaD
Gallium nitrate—Tachycardia—Cisplatin—urinary bladder cancer	0.000168	0.00331	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—IL2—urinary bladder cancer	0.000168	0.00203	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—ERBB2—urinary bladder cancer	0.000167	0.00202	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000165	0.00327	CcSEcCtD
Gallium nitrate—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000164	0.00325	CcSEcCtD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000163	0.00197	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000163	0.00322	CcSEcCtD
Gallium nitrate—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000162	0.00319	CcSEcCtD
Gallium nitrate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000161	0.00319	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—CDK4—urinary bladder cancer	0.000159	0.00193	CbGpPWpGaD
Gallium nitrate—Confusional state—Etoposide—urinary bladder cancer	0.000159	0.00314	CcSEcCtD
Gallium nitrate—Constipation—Gemcitabine—urinary bladder cancer	0.000158	0.00312	CcSEcCtD
Gallium nitrate—Pruritus—Thiotepa—urinary bladder cancer	0.000155	0.00306	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—RBX1—urinary bladder cancer	0.000155	0.00188	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—HRAS—urinary bladder cancer	0.000154	0.00187	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Cisplatin—urinary bladder cancer	0.000154	0.00305	CcSEcCtD
Gallium nitrate—Tachycardia—Etoposide—urinary bladder cancer	0.000154	0.00304	CcSEcCtD
Gallium nitrate—Dyspnoea—Cisplatin—urinary bladder cancer	0.000153	0.00303	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000153	0.00185	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—LIG1—urinary bladder cancer	0.000152	0.00184	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000152	0.003	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—CXCL8—urinary bladder cancer	0.000152	0.00184	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—RB1—urinary bladder cancer	0.000152	0.00184	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IGF1—urinary bladder cancer	0.00015	0.00182	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.00015	0.00182	CbGpPWpGaD
Gallium nitrate—RRM2—G1/S Transition—RB1—urinary bladder cancer	0.00015	0.00182	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Thiotepa—urinary bladder cancer	0.00015	0.00296	CcSEcCtD
Gallium nitrate—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000149	0.00295	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—CDKN1A—urinary bladder cancer	0.000148	0.0018	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—CCND1—urinary bladder cancer	0.000147	0.00179	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000146	0.00288	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDK4—urinary bladder cancer	0.000145	0.00176	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—IL2—urinary bladder cancer	0.000145	0.00176	CbGpPWpGaD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	0.000145	0.00175	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000144	0.00174	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	0.000143	0.00174	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	0.000143	0.00174	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000143	0.00283	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000143	0.00173	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000142	0.0028	CcSEcCtD
Gallium nitrate—Paraesthesia—Etoposide—urinary bladder cancer	0.000141	0.00279	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—EP300—urinary bladder cancer	0.000141	0.00171	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Etoposide—urinary bladder cancer	0.00014	0.00277	CcSEcCtD
Gallium nitrate—Vomiting—Thiotepa—urinary bladder cancer	0.000139	0.00275	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—RB1—urinary bladder cancer	0.000138	0.00168	CbGpPWpGaD
Gallium nitrate—Rash—Thiotepa—urinary bladder cancer	0.000138	0.00273	CcSEcCtD
Gallium nitrate—Dermatitis—Thiotepa—urinary bladder cancer	0.000138	0.00273	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—FAS—urinary bladder cancer	0.000136	0.00165	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Cisplatin—urinary bladder cancer	0.000136	0.00269	CcSEcCtD
Gallium nitrate—Constipation—Etoposide—urinary bladder cancer	0.000135	0.00266	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HDAC4—urinary bladder cancer	0.000134	0.00162	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000133	0.00264	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CDKN2A—urinary bladder cancer	0.000133	0.00162	CbGpPWpGaD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	0.000133	0.00162	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—SRC—urinary bladder cancer	0.000132	0.0016	CbGpPWpGaD
Gallium nitrate—Pruritus—Gemcitabine—urinary bladder cancer	0.00013	0.00258	CcSEcCtD
Gallium nitrate—Nausea—Thiotepa—urinary bladder cancer	0.00013	0.00257	CcSEcCtD
Gallium nitrate—Feeling abnormal—Etoposide—urinary bladder cancer	0.00013	0.00256	CcSEcCtD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	0.000129	0.00156	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—STAG2—urinary bladder cancer	0.000128	0.00155	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—LIG1—urinary bladder cancer	0.000128	0.00155	CbGpPWpGaD
Gallium nitrate—Pruritus—Fluorouracil—urinary bladder cancer	0.000128	0.00253	CcSEcCtD
Gallium nitrate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000127	0.0025	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—RB1—urinary bladder cancer	0.000126	0.00153	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000126	0.00249	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—RHOA—urinary bladder cancer	0.000125	0.00152	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Etoposide—urinary bladder cancer	0.000124	0.00246	CcSEcCtD
Gallium nitrate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000124	0.00245	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—CXCL8—urinary bladder cancer	0.000124	0.0015	CbGpPWpGaD
Gallium nitrate—Tinnitus—Methotrexate—urinary bladder cancer	0.000124	0.00245	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—MYC—urinary bladder cancer	0.000123	0.00149	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000122	0.00242	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—TNF—urinary bladder cancer	0.000122	0.00148	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CXCL8—urinary bladder cancer	0.000121	0.00147	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IFNA2—urinary bladder cancer	0.000119	0.00144	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Cisplatin—urinary bladder cancer	0.000118	0.00232	CcSEcCtD
Gallium nitrate—Vomiting—Gemcitabine—urinary bladder cancer	0.000117	0.00232	CcSEcCtD
Gallium nitrate—Rash—Gemcitabine—urinary bladder cancer	0.000116	0.0023	CcSEcCtD
Gallium nitrate—Dermatitis—Gemcitabine—urinary bladder cancer	0.000116	0.0023	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—ENO2—urinary bladder cancer	0.000116	0.00141	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000116	0.00229	CcSEcCtD
Gallium nitrate—Tinnitus—Epirubicin—urinary bladder cancer	0.000116	0.00229	CcSEcCtD
Gallium nitrate—Erythema—Methotrexate—urinary bladder cancer	0.000115	0.00228	CcSEcCtD
Gallium nitrate—Vomiting—Fluorouracil—urinary bladder cancer	0.000115	0.00228	CcSEcCtD
Gallium nitrate—Rash—Fluorouracil—urinary bladder cancer	0.000114	0.00226	CcSEcCtD
Gallium nitrate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000114	0.00226	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000114	0.00138	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—PTGS2—urinary bladder cancer	0.000114	0.00138	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000113	0.00224	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—IL2—urinary bladder cancer	0.000113	0.00137	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—GLI1—urinary bladder cancer	0.000112	0.00136	CbGpPWpGaD
Gallium nitrate—Pruritus—Etoposide—urinary bladder cancer	0.000111	0.0022	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN2A—urinary bladder cancer	0.000111	0.00135	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000111	0.00134	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—CXCL8—urinary bladder cancer	0.00011	0.00134	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—RBX1—urinary bladder cancer	0.00011	0.00133	CbGpPWpGaD
Gallium nitrate—Nausea—Gemcitabine—urinary bladder cancer	0.000109	0.00216	CcSEcCtD
Gallium nitrate—Vomiting—Cisplatin—urinary bladder cancer	0.000109	0.00216	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CDKN1A—urinary bladder cancer	0.000109	0.00132	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—PTEN—urinary bladder cancer	0.000109	0.00132	CbGpPWpGaD
Gallium nitrate—Rash—Cisplatin—urinary bladder cancer	0.000108	0.00214	CcSEcCtD
Gallium nitrate—Dermatitis—Cisplatin—urinary bladder cancer	0.000108	0.00214	CcSEcCtD
Gallium nitrate—Erythema—Epirubicin—urinary bladder cancer	0.000108	0.00214	CcSEcCtD
Gallium nitrate—RRM2—G1/S Transition—CDKN1A—urinary bladder cancer	0.000108	0.00131	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Etoposide—urinary bladder cancer	0.000108	0.00213	CcSEcCtD
Gallium nitrate—Nausea—Fluorouracil—urinary bladder cancer	0.000108	0.00213	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—TP53—urinary bladder cancer	0.000108	0.0013	CbGpPWpGaD
Gallium nitrate—Tinnitus—Doxorubicin—urinary bladder cancer	0.000107	0.00212	CcSEcCtD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	0.000107	0.0013	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.000107	0.0013	CbGpPWpGaD
Gallium nitrate—Anaemia—Methotrexate—urinary bladder cancer	0.000107	0.00211	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—TNF—urinary bladder cancer	0.000106	0.00128	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—TNF—urinary bladder cancer	0.000106	0.00128	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—IL2—urinary bladder cancer	0.000105	0.00128	CbGpPWpGaD
Gallium nitrate—Leukopenia—Methotrexate—urinary bladder cancer	0.000103	0.00204	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000103	0.00125	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—CCND1—urinary bladder cancer	0.000103	0.00124	CbGpPWpGaD
Gallium nitrate—Nausea—Cisplatin—urinary bladder cancer	0.000102	0.00202	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—GSTZ1—urinary bladder cancer	0.000101	0.00123	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—SRC—urinary bladder cancer	0.000101	0.00122	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	0.0001	0.00122	CbGpPWpGaD
Gallium nitrate—Vomiting—Etoposide—urinary bladder cancer	0.0001	0.00198	CcSEcCtD
Gallium nitrate—Erythema—Doxorubicin—urinary bladder cancer	0.0001	0.00198	CcSEcCtD
Gallium nitrate—Anaemia—Epirubicin—urinary bladder cancer	9.99e-05	0.00198	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—MMP9—urinary bladder cancer	9.96e-05	0.00121	CbGpPWpGaD
Gallium nitrate—Rash—Etoposide—urinary bladder cancer	9.92e-05	0.00196	CcSEcCtD
Gallium nitrate—Dermatitis—Etoposide—urinary bladder cancer	9.91e-05	0.00196	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—JAG1—urinary bladder cancer	9.84e-05	0.00119	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	9.8e-05	0.00119	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	9.75e-05	0.00118	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.7e-05	0.00118	CbGpPWpGaD
Gallium nitrate—Leukopenia—Epirubicin—urinary bladder cancer	9.67e-05	0.00191	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—CXCL8—urinary bladder cancer	9.66e-05	0.00117	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GSTO2—urinary bladder cancer	9.59e-05	0.00116	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—NAT1—urinary bladder cancer	9.59e-05	0.00116	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—IFNA2—urinary bladder cancer	9.54e-05	0.00116	CbGpPWpGaD
Gallium nitrate—Confusional state—Methotrexate—urinary bladder cancer	9.5e-05	0.00188	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CCND1—urinary bladder cancer	9.38e-05	0.00114	CbGpPWpGaD
Gallium nitrate—Nausea—Etoposide—urinary bladder cancer	9.35e-05	0.00185	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—TP53—urinary bladder cancer	9.32e-05	0.00113	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—HRAS—urinary bladder cancer	9.29e-05	0.00113	CbGpPWpGaD
Gallium nitrate—Anaemia—Doxorubicin—urinary bladder cancer	9.24e-05	0.00183	CcSEcCtD
Gallium nitrate—IL1B—Immune System—PRSS3—urinary bladder cancer	9.23e-05	0.00112	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN1A—urinary bladder cancer	9.08e-05	0.0011	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—SMC1A—urinary bladder cancer	8.98e-05	0.00109	CbGpPWpGaD
Gallium nitrate—Leukopenia—Doxorubicin—urinary bladder cancer	8.95e-05	0.00177	CcSEcCtD
Gallium nitrate—RRM2—G1/S Transition—MYC—urinary bladder cancer	8.93e-05	0.00108	CbGpPWpGaD
Gallium nitrate—Confusional state—Epirubicin—urinary bladder cancer	8.89e-05	0.00176	CcSEcCtD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.82e-05	0.00107	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	8.81e-05	0.00107	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—VHL—urinary bladder cancer	8.81e-05	0.00107	CbGpPWpGaD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	8.78e-05	0.00106	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—UGT2B7—urinary bladder cancer	8.77e-05	0.00106	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—TNF—urinary bladder cancer	8.62e-05	0.00104	CbGpPWpGaD
Gallium nitrate—Tachycardia—Epirubicin—urinary bladder cancer	8.61e-05	0.0017	CcSEcCtD
Gallium nitrate—Paraesthesia—Methotrexate—urinary bladder cancer	8.46e-05	0.00167	CcSEcCtD
Gallium nitrate—Dyspnoea—Methotrexate—urinary bladder cancer	8.4e-05	0.00166	CcSEcCtD
Gallium nitrate—IL1B—Immune System—MT2A—urinary bladder cancer	8.28e-05	0.001	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—MYC—urinary bladder cancer	8.23e-05	0.000998	CbGpPWpGaD
Gallium nitrate—Confusional state—Doxorubicin—urinary bladder cancer	8.23e-05	0.00163	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	8.22e-05	0.000996	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—KRAS—urinary bladder cancer	8.17e-05	0.00099	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—EGFR—urinary bladder cancer	8.05e-05	0.000976	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—HRAS—urinary bladder cancer	8.03e-05	0.000973	CbGpPWpGaD
Gallium nitrate—Tachycardia—Doxorubicin—urinary bladder cancer	7.97e-05	0.00158	CcSEcCtD
Gallium nitrate—Paraesthesia—Epirubicin—urinary bladder cancer	7.92e-05	0.00157	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	7.91e-05	0.000959	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CYP4B1—urinary bladder cancer	7.9e-05	0.000957	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Epirubicin—urinary bladder cancer	7.86e-05	0.00156	CcSEcCtD
Gallium nitrate—Feeling abnormal—Methotrexate—urinary bladder cancer	7.77e-05	0.00154	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—RBX1—urinary bladder cancer	7.7e-05	0.000933	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TNF—urinary bladder cancer	7.67e-05	0.000929	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	7.56e-05	0.000916	CbGpPWpGaD
Gallium nitrate—Constipation—Epirubicin—urinary bladder cancer	7.54e-05	0.00149	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—MYC—urinary bladder cancer	7.53e-05	0.000912	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—SLC19A1—urinary bladder cancer	7.46e-05	0.000904	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Methotrexate—urinary bladder cancer	7.45e-05	0.00147	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—TP53—urinary bladder cancer	7.42e-05	0.0009	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Doxorubicin—urinary bladder cancer	7.33e-05	0.00145	CcSEcCtD
Gallium nitrate—Dyspnoea—Doxorubicin—urinary bladder cancer	7.28e-05	0.00144	CcSEcCtD
Gallium nitrate—Feeling abnormal—Epirubicin—urinary bladder cancer	7.27e-05	0.00144	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—PRSS3—urinary bladder cancer	7.27e-05	0.000881	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TSC1—urinary bladder cancer	7.24e-05	0.000877	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	7.17e-05	0.000869	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—NCOR1—urinary bladder cancer	7.16e-05	0.000868	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—HRAS—urinary bladder cancer	7.1e-05	0.00086	CbGpPWpGaD
Gallium nitrate—Constipation—Doxorubicin—urinary bladder cancer	6.98e-05	0.00138	CcSEcCtD
Gallium nitrate—Body temperature increased—Epirubicin—urinary bladder cancer	6.97e-05	0.00138	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	6.96e-05	0.000844	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Methotrexate—urinary bladder cancer	6.94e-05	0.00137	CcSEcCtD
Gallium nitrate—IL1B—Signaling by Interleukins—HRAS—urinary bladder cancer	6.94e-05	0.000841	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—JAG1—urinary bladder cancer	6.89e-05	0.000835	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	6.84e-05	0.000828	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—PLAU—urinary bladder cancer	6.77e-05	0.00082	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TP53—urinary bladder cancer	6.76e-05	0.000819	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ERCC2—urinary bladder cancer	6.74e-05	0.000816	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TNF—urinary bladder cancer	6.73e-05	0.000815	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Doxorubicin—urinary bladder cancer	6.73e-05	0.00133	CcSEcCtD
Gallium nitrate—Pruritus—Methotrexate—urinary bladder cancer	6.67e-05	0.00132	CcSEcCtD
Gallium nitrate—Hypersensitivity—Epirubicin—urinary bladder cancer	6.5e-05	0.00129	CcSEcCtD
Gallium nitrate—Body temperature increased—Doxorubicin—urinary bladder cancer	6.45e-05	0.00128	CcSEcCtD
Gallium nitrate—Diarrhoea—Methotrexate—urinary bladder cancer	6.45e-05	0.00128	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—MTHFR—urinary bladder cancer	6.33e-05	0.000767	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—TERT—urinary bladder cancer	6.31e-05	0.000765	CbGpPWpGaD
Gallium nitrate—Pruritus—Epirubicin—urinary bladder cancer	6.24e-05	0.00123	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—CCNE1—urinary bladder cancer	6.22e-05	0.000754	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—MYC—urinary bladder cancer	6.21e-05	0.000752	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—BIRC3—urinary bladder cancer	6.16e-05	0.000747	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	6.13e-05	0.000743	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—TYMS—urinary bladder cancer	6.11e-05	0.000741	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—EGFR—urinary bladder cancer	6.07e-05	0.000736	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Epirubicin—urinary bladder cancer	6.04e-05	0.00119	CcSEcCtD
Gallium nitrate—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.01e-05	0.00119	CcSEcCtD
Gallium nitrate—Vomiting—Methotrexate—urinary bladder cancer	5.99e-05	0.00119	CcSEcCtD
Gallium nitrate—Rash—Methotrexate—urinary bladder cancer	5.94e-05	0.00118	CcSEcCtD
Gallium nitrate—Dermatitis—Methotrexate—urinary bladder cancer	5.94e-05	0.00117	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—TYMP—urinary bladder cancer	5.81e-05	0.000704	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—FGFR3—urinary bladder cancer	5.79e-05	0.000702	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TNF—urinary bladder cancer	5.78e-05	0.000701	CbGpPWpGaD
Gallium nitrate—Pruritus—Doxorubicin—urinary bladder cancer	5.77e-05	0.00114	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—KRAS—urinary bladder cancer	5.73e-05	0.000695	CbGpPWpGaD
Gallium nitrate—Vomiting—Epirubicin—urinary bladder cancer	5.61e-05	0.00111	CcSEcCtD
Gallium nitrate—Nausea—Methotrexate—urinary bladder cancer	5.6e-05	0.00111	CcSEcCtD
Gallium nitrate—Diarrhoea—Doxorubicin—urinary bladder cancer	5.58e-05	0.0011	CcSEcCtD
Gallium nitrate—TF—Hemostasis—CREBBP—urinary bladder cancer	5.58e-05	0.000677	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—S100B—urinary bladder cancer	5.58e-05	0.000676	CbGpPWpGaD
Gallium nitrate—Rash—Epirubicin—urinary bladder cancer	5.56e-05	0.0011	CcSEcCtD
Gallium nitrate—Dermatitis—Epirubicin—urinary bladder cancer	5.56e-05	0.0011	CcSEcCtD
Gallium nitrate—TF—Hemostasis—IGF1—urinary bladder cancer	5.51e-05	0.000668	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	5.33e-05	0.000646	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—TERT—urinary bladder cancer	5.32e-05	0.000645	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL2—urinary bladder cancer	5.27e-05	0.000639	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—NAT2—urinary bladder cancer	5.25e-05	0.000637	CbGpPWpGaD
Gallium nitrate—Nausea—Epirubicin—urinary bladder cancer	5.24e-05	0.00104	CcSEcCtD
Gallium nitrate—Vomiting—Doxorubicin—urinary bladder cancer	5.19e-05	0.00103	CcSEcCtD
Gallium nitrate—Rash—Doxorubicin—urinary bladder cancer	5.15e-05	0.00102	CcSEcCtD
Gallium nitrate—Dermatitis—Doxorubicin—urinary bladder cancer	5.14e-05	0.00102	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TP53—urinary bladder cancer	5.1e-05	0.000618	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—RBX1—urinary bladder cancer	5.06e-05	0.000613	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—RHOA—urinary bladder cancer	5.05e-05	0.000612	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NCOR1—urinary bladder cancer	5.02e-05	0.000608	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CREBBP—urinary bladder cancer	4.93e-05	0.000598	CbGpPWpGaD
Gallium nitrate—Nausea—Doxorubicin—urinary bladder cancer	4.85e-05	0.000959	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.83e-05	0.000586	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—ATM—urinary bladder cancer	4.79e-05	0.00058	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDK4—urinary bladder cancer	4.77e-05	0.000578	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—RB1—urinary bladder cancer	4.63e-05	0.000562	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—RHOA—urinary bladder cancer	4.46e-05	0.000541	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TERT—urinary bladder cancer	4.42e-05	0.000536	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—IL2—urinary bladder cancer	4.24e-05	0.000514	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—HPGDS—urinary bladder cancer	4.2e-05	0.000509	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ENO2—urinary bladder cancer	4.2e-05	0.000509	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—RB1—urinary bladder cancer	4.14e-05	0.000502	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—ERBB2—urinary bladder cancer	4.13e-05	0.000501	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GSTT1—urinary bladder cancer	4.07e-05	0.000494	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	4.07e-05	0.000494	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—FGFR3—urinary bladder cancer	4.06e-05	0.000492	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PTGS2—urinary bladder cancer	4.04e-05	0.00049	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ESR1—urinary bladder cancer	3.94e-05	0.000478	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IFNA2—urinary bladder cancer	3.88e-05	0.00047	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—KRAS—urinary bladder cancer	3.81e-05	0.000462	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—EP300—urinary bladder cancer	3.8e-05	0.000461	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—SRC—urinary bladder cancer	3.7e-05	0.000448	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—S100B—urinary bladder cancer	3.67e-05	0.000444	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN2A—urinary bladder cancer	3.64e-05	0.000441	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CDKN1A—urinary bladder cancer	3.53e-05	0.000428	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PTEN—urinary bladder cancer	3.52e-05	0.000427	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CREBBP—urinary bladder cancer	3.45e-05	0.000419	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	3.44e-05	0.000417	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IGF1—urinary bladder cancer	3.41e-05	0.000413	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—NQO1—urinary bladder cancer	3.39e-05	0.00041	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—EP300—urinary bladder cancer	3.36e-05	0.000407	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	3.33e-05	0.000404	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—SRC—urinary bladder cancer	3.27e-05	0.000396	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—HRAS—urinary bladder cancer	3.24e-05	0.000393	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—EP300—urinary bladder cancer	3.17e-05	0.000384	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—RHOA—urinary bladder cancer	3.12e-05	0.000379	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CCND1—urinary bladder cancer	3.08e-05	0.000373	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—KRAS—urinary bladder cancer	3.06e-05	0.000371	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN1A—urinary bladder cancer	2.98e-05	0.000361	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—MYC—urinary bladder cancer	2.93e-05	0.000355	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—ERBB2—urinary bladder cancer	2.89e-05	0.000351	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—EGFR—urinary bladder cancer	2.86e-05	0.000347	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—EP300—urinary bladder cancer	2.83e-05	0.000343	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GSTP1—urinary bladder cancer	2.82e-05	0.000342	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—MYC—urinary bladder cancer	2.76e-05	0.000335	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CXCL8—urinary bladder cancer	2.74e-05	0.000332	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TP53—urinary bladder cancer	2.72e-05	0.00033	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—KRAS—urinary bladder cancer	2.7e-05	0.000328	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—FGFR3—urinary bladder cancer	2.67e-05	0.000323	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—TYMS—urinary bladder cancer	2.63e-05	0.000318	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—IL2—urinary bladder cancer	2.62e-05	0.000318	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—HRAS—urinary bladder cancer	2.6e-05	0.000315	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GSTM1—urinary bladder cancer	2.6e-05	0.000315	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—NCOR1—urinary bladder cancer	2.6e-05	0.000315	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CCND1—urinary bladder cancer	2.56e-05	0.00031	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GPX1—urinary bladder cancer	2.49e-05	0.000301	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MMP9—urinary bladder cancer	2.48e-05	0.000301	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.47e-05	0.0003	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—MYC—urinary bladder cancer	2.47e-05	0.000299	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PTEN—urinary bladder cancer	2.47e-05	0.000299	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ERCC2—urinary bladder cancer	2.44e-05	0.000296	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—EP300—urinary bladder cancer	2.35e-05	0.000285	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HRAS—urinary bladder cancer	2.3e-05	0.000279	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—MTHFR—urinary bladder cancer	2.29e-05	0.000278	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—SRC—urinary bladder cancer	2.29e-05	0.000277	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CREBBP—urinary bladder cancer	2.27e-05	0.000275	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CDH1—urinary bladder cancer	2.25e-05	0.000273	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MYC—urinary bladder cancer	2.05e-05	0.000248	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—TP53—urinary bladder cancer	2.03e-05	0.000246	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—EGFR—urinary bladder cancer	2e-05	0.000243	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—ERBB2—urinary bladder cancer	1.9e-05	0.00023	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—KRAS—urinary bladder cancer	1.89e-05	0.00023	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PPARG—urinary bladder cancer	1.86e-05	0.000225	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CREBBP—urinary bladder cancer	1.79e-05	0.000217	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IL2—urinary bladder cancer	1.72e-05	0.000209	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TP53—urinary bladder cancer	1.68e-05	0.000204	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CDKN1A—urinary bladder cancer	1.62e-05	0.000197	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—PTEN—urinary bladder cancer	1.62e-05	0.000196	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HRAS—urinary bladder cancer	1.61e-05	0.000195	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—EP300—urinary bladder cancer	1.55e-05	0.000187	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—SRC—urinary bladder cancer	1.5e-05	0.000182	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PTGS2—urinary bladder cancer	1.46e-05	0.000177	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—EGFR—urinary bladder cancer	1.32e-05	0.00016	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PTEN—urinary bladder cancer	1.28e-05	0.000155	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—KRAS—urinary bladder cancer	1.24e-05	0.000151	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—EP300—urinary bladder cancer	1.22e-05	0.000147	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—HRAS—urinary bladder cancer	1.06e-05	0.000128	CbGpPWpGaD
